The Re-Vario™-A technology platform is the basis for a reusable injection pen for use in diabetes treatment and other areas of care. Specifically created to provide a high-quality pen at an affordable cost, this innovative pen technology platform is available in standard Haselmeier design or can be customized to your specific requirements.
High-quality technology at an affordable cost
High-quality technology at an affordable cost

The Re-Vario™-A technology platform delivers patient-centric Haselmeier quality at an affordable cost.
The Re-Vario™-A technology platform delivers patient-centric Haselmeier quality at an affordable cost.
An economical solution
High-quality reusable plastic product platformWith easy customization
Dose increments from 0.01 ml to 0.6 mlA versatile solution
Multiple injections and variable dosage
Safe to use for patients
Easy and safe dose correctionClear and easy to read
Large and easy-to-read dose indicatorA reusable injection device
For use with a standard 3 ml cartridgeDatasheet - PDF
A closer look at the platform
Balancing cost against
time-to-market
Balancing cost against
time-to-market
Our Re-Vario™-A technology platform helps you to accelerate time-to-market. The Re-Vario™-A technology is the basis for a reusable injection device for variable dosage is based on an established infrastructure for production and certification processes. At the same time, the Re-Vario™-A technology platform offers high flexibility and variability in design and appearance. It offers a viable option for pharmaceutical companies and meets the needs of patients worldwide.

Packaging
Modern packaging for customized pens
Modern packaging for customized pens
We offer high end packaging design services that complement your products.
-
Areas of care
-
Areas of care
-
Areas of care
-
Areas of care
Diabetes GLP-1
Diabetes GLP-1
Haselmeier offers pen solutions that support safe and efficient self-injection of GLP-1 – helping diabetes patients to manage their condition, and so aiding efforts to reduce costs and improve quality of care.
Diabetes Insulin
Diabetes Insulin
Haselmeier offers customizable injection pens and platform solutions that help type 1 and type 2 diabetes patients to self-administer insulin, promoting better compliance and more effective treatment.
Osteoporosis
Osteoporosis
We support convenience and compliance in osteoporosis treatment. The D-Flex™ pen can significantly improve therapy efficiency, allowing patients to treat themselves safely and discreetly on a long-term basis.
Oncology
Oncology
Haselmeier's customizable pen solutions are suitable for use in some areas of oncology, supporting quality of care in this growing clinical domain. The solutions could improve patients' quality of life and create a basis for reliable and successful therapy at home.
Let's talk about your customized injection pen
Let's talk about your customized injection pen
As a full-service provider, Haselmeier solutions include more than R&D consulting, product engineering, and development services. We also provide certified pharmaceutical manufacturing services, and so are able to offer a comprehensive assembly, labeling and packaging services including intellectual property and technology licensing assistance.